Persistent URL of this record https://hdl.handle.net/1887/3564998
Documents
-
- Download
- 1-s2.0-S0169500222004640-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors
- All authors
- Cuppens, K.; Baas, P.; Geerdens, E.; Cruys, B.; Froyen, G.; Decoster, L.; Thomeer, M.; Maes, B.
- Date
- 2022-06-08
- Journal
- Lung Cancer
- Volume
- 170
- Pages
- 1 - 10